Product Code: GVR-1-68038-918-0
Orthopedic Bone Cement Market Growth & Trends:
The global orthopedic bone cement market size is expected to reach USD 975.7 million by 2030, and is projected to register a CAGR of 5.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as rising demand for minimally invasive procedures, advancements in casting materials and techniques, and the growing prevalence of orthopedic disorders and injuries drive the market's growth. For instance, according to a study published by the Institute for Health Metrics and Evaluation in August 2023, osteoarthritis affects 15% of the global population over the age of 30.
Furthermore, the rise in bone fracture cases boosts the demand for orthopedic bone cement products. For instance, according to the World Osteoporosis Day Survey 2023 conducted by the International Osteoporosis Foundation, 43% of the surveyed women reported that they had broken a bone following a bump or a minor fall after age 50. In addition, according to an article published by ScienceDirect in June 2023, the prevalence of hip fractures in India is estimated to be more than 120 fractures per 100,000 individuals aged over 50 annually.
Manufacturers have launched antibiotic-loaded cement that reduces the chances of post-surgical infections, particularly in total joint arthroplasty. Advancements in end-use technology are expected to boost the adoption of orthopedic bone cement among surgeons. Furthermore, the rising aging population is crucial in fueling the demand for bone cement. The geriatric population is at a higher risk of fractures and related injuries and frequently needs joint replacement procedures. This cement provides a better alternative to wires and screws, which can create discomfort for the patients.
Some of the key players in the market are Stryker, Zimmer Biomet, DePuy Synthes, Smith & Nephew, DJO Global Inc. (Enovis), Arthrex Inc., Tecres S.p.A. (Demetra Holding S.p.A.), Heraeus Medical LLC, and Cardinal Health. Players are adopting key strategic initiatives to expand their business footprint and grow their clientele. For instance, in July 2022, GRAFTYS SA, a manufacturer of resorbable bone cement, raised funding of USD 2.20 million from its existing shareholders to accelerate commercial advancement and the introduction of new products.
Orthopedic Bone Cement Market Report Highlights:
- Based on material, the polymethyl methacrylate (PMMA) segment dominated the market in 2023 with the largest revenue share. Bone cement, consisting of PMMA, is a bioinert material used for prosthesis fixation in joint arthroplasty.
- Based on product, the antibiotic-loaded bone cement segment dominated the market in 2023. Antibiotic-loaded cement helps improve implant fixation and reduce the deep surgical site infection rate following hemiarthroplasty.
- Based on end-use, the hospitals segment dominated the market in 2023, owing to their dominance in developing and low-income nations, as many patients visit the hospitals.
- North America dominated the global market due to government initiatives to accelerate research activities for orthopedic conditions, the presence of many market players, and the launch of a diverse range of products.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Material outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Orthopedic Bone Cement Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Orthopedic Bone Cement: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
- 3.4. Product Pipeline Analysis
- 3.5. Case Study Analysis
Chapter 4. Orthopedic Bone Cement Market Segment Analysis, By Product, 2018 - 2030 (USD Million)
- 4.1. Definition and Scope
- 4.2. Product Market Share Analysis, 2023 & 2030
- 4.3. Segment Dashboard
- 4.4. Global orthopedic bone cement market, by product, 2018 to 2030
- 4.5. Bone Cement Without Antibiotics
- 4.5.1. Bone Cement Without Antibiotics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Antibiotic Loaded Bone Cement
- 4.6.1. Antibiotic Loaded Bone Cement market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Orthopedic Bone Cement Market Segment Analysis, By Material, 2018 - 2030 (USD Million)
- 5.1. Definition and Scope
- 5.2. Material Market Share Analysis, 2023 & 2030
- 5.3. Segment Dashboard
- 5.4. Global orthopedic bone cement market, by material, 2018 to 2030
- 5.5. Polymethyl Methacrylate (PMMA)
- 5.5.1. Polymethyl Methacrylate (PMMA) market estimates and forecasts, 2018 to 2030 (USD million)
- 5.6. Calcium phosphate
- 5.6.1. Calcium phosphate market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Glass Polyalkeonate
- 5.7.1. Glass Polyalkeonate market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Orthopedic Bone Cement Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
- 6.1. Definition and Scope
- 6.2. End Use Market Share Analysis, 2023 & 2030
- 6.3. Segment Dashboard
- 6.4. Global orthopedic bone cement Market, by End Use, 2018 to 2030
- 6.5. Hospitals
- 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD million)
- 6.6. Outpatient facilities
- 6.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Orthopedic Bone Cement Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Orthopedic Bone Cement Market Share by Region, 2023 & 2030:
- 7.5. North America
- 7.5.1. North America orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. U.S. orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Canada orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Mexico orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Europe orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6.2. UK
- 7.6.2.1. UK orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Germany orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. France orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Italy orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Spain orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6.7. Norway
- 7.6.7.1. Norway orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Sweden orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.6.9. Denmark
- 7.6.9.1. Denmark orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Japan orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. China orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. India orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Australia orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. South Korea orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Thailand orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Brazil orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Argentina orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. South Africa orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Saudi Arabia orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. UAE orthopedic bone cement market, 2018 - 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Kuwait orthopedic bone cement market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Profiles
- 8.3.1. Stryker
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Zimmer Biomet
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. DePuy Synthes
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Smith & Nephew
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Arthrex Inc
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. DJO Global Inc. (Enovis)
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Tecres S.p.A. (Demetra Holding S.p.A.)
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Heraeus Medical GmbH
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Cardinal Health
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives